Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. (ABOS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABOS · as of Jun 9, 2026
Key Statistics
Explore Acumen Pharmaceuticals, Inc. Data
abos stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The ABOS analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +222.58% upside from the current price of $2.17.
Competitors & Peers
abos competitorsABOS
ACTU
AGEN
ALEC
FATE
INOStock Performance
Full HistoryAbout Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus …
what is acumen pharmaceuticals, inc. · abos stock overview · acumen pharmaceuticals, inc. company profile · who is acumen pharmaceuticals, inc. ceo · abos NASDAQ · acumen pharmaceuticals, inc. headquarters · acumen pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Acumen Pharmaceuticals, Inc. (ABOS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 1, 2021. As of the latest trading session, ABOS stock price is $2.17, with a market capitalization of $131.4M. The stock has returned +70.87% over the past 12 months and +2.84% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Acumen Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $7.00. In fiscal year 2025, Acumen Pharmaceuticals, Inc. reported revenue of — and net income of -$121.3M. For detailed data — including Acumen Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Acumen Pharmaceuticals, Inc. (ABOS) stock price is $2.17. The stock is traded on NASDAQ under the ticker symbol ABOS. The 52-week range is $1.05 – $3.60.